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Is atopy a risk indicator of chronic
obstructive pulmonary disease in dairy
farmers?
Matthieu Veil-Picard1†, Thibaud Soumagne1†, Rechana Vongthilath1, Isabella Annesi-Maesano2, Alicia Guillien3,
Lucie Laurent1, Pascal Andujar4,5, Nicolas Roche6, Stephane Jouneau7,8, Benoit Cypriani9, Jean-Jacques Laplante10,
Bruno Degano11,12 and Jean-Charles Dalphin1,13*
Abstract: Allergic mechanisms related to environmental and occupational exposure have been suggested to
contribute to the development of chronic obstructive pulmonary disease (COPD).
Objectives: To investigate the relationships between atopy markers, persistent airflow limitation (PAL) and
occupational exposure in dairy farmers.
Methods: Clinical and biological (total IgE and 21 allergen specific IgE) markers of atopy were assessed in 101 dairy
farmers with PAL (DF-PAL), 85 non-farmers with PAL (NF-PAL) (both groups were prospectively included from a
screening program performed between 2011 and 2015), and matched controls, i.e. 98 farmers without PAL (DF-
controls) and 89 non-farming subjects without PAL (NF-controls). Occupational exposure in farmers was estimated
using a validated questionnaire.
Results: Prevalence of allergy history was significantly higher in DF-PAL and in NF-PAL than in controls.
Polysensitization, and sensitization to seasonal and food allergens were more frequent in DF-PAL than in DF-
controls, respectively: 13.8% vs 1% (adjusted odds ratio (aOR): 17.5 (2.2–134), 11.9% vs 3.1% (aOR: 4.4 (1.2–7.2)
and 16.8% vs 4.1% (aOR: 5.2 (1.7–7.2)). The prevalence of atopy markers was similar between NF-PAL patients
and NF-controls.
Conclusions: PAL in farmers is associated with a high rate of markers of atopy, supporting atopy as a risk
indicator.
Clinical trial registered with ClinicalTrials.gov (NCT02540408).
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Chronic obstructive pulmonary disease (COPD) is a pre-
ventable and treatable disease, characterized by persist-
ent airflow limitation, which is usually progressive [1].
The most important etiological factor for COPD is to-
bacco smoking, but many other factors can trigger the
lung inflammation leading to COPD. Occupational
exposure to vapors, gas, dust or fumes ranks high among
these factors, and accounts for 20% of COPD in devel-
oped countries [2, 3]. Biological dusts may be associated
with a higher risk of occupational COPD than mineral
dusts [3]. Exposure to organic dusts has been shown to
be associated with an increased risk of obstructive lung
diseases, especially in dairy farmers [4, 5].
Although the pathophysiological traits of tobacco-
related COPD are now well described, there are very few
studies that have specifically assessed the pathophysi-
ology of COPD related to organic dust exposure. Inflam-
matory response in tobacco-related COPD is dominated
by Th1-type lymphocyte response, along with Th17
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cytokine production [6] . By contrast, COPD induced by
inhalation of biomass fumes could be associated with a
predominantly Th2-type lymphocyte production profile,
in addition to an increase in IL-4 [7].
Although there is some evidence suggesting a link
between atopy and a lower FEV1 [8–10] related to or-
ganic dust exposure, especially in non-smokers, a com-
prehensive study of atopic response and the presence of
PAL in dairy farmers using non-PAL dairy farmers as
controls, as well as in subjects with or without PAL in
the general population, is lacking. Since we speculate
that PAL in dairy farmers may involve IgE-mediated
reactions, we aimed to analyze the relationship between
PAL, clinical and biological markers of atopy in farming
and non-farming subjects.
Methods
Study design and subjects
Data for this study were collected as part of the BALISTIC
project (COPD in dairy farmers: screening, characterization
and constitution of a cohort; ClinicalTrials.gov Identifier:
NCT02540408) (see additional file 1) [11].
A diagnosis of PAL was retained when the FEV1/FVC
ratio post-bronchodilator was less than 0.70. PAL pa-
tients were rated either as stage 1 (i.e., FEV1 was > 80%
of the predicted value) or stage 2+ (i.e., FEV1 was ≤80%
of the predicted value). Spirometry was considered nor-
mal when the FEV1/FVC ratio was > 0.70 and FEV1 was
> 80% of the predicted value before bronchodilator
administration. Predicted values were based on the GLI
equations [12].
All subjects in whom PAL was detected during the
“screening phase” were invited to participate in the
“characterization” phase of the study. Those who ac-
cepted to participate in this “characterization” phase
were included in two subgroups, namely dairy farmers
with PAL (DF-PAL) and non-farmers with PAL (NF-
PAL). Subjects with normal spirometry who had partici-
pated in the “screening” phase of the study were fre-
quency matched with the PAL subjects in terms of age,
body mass index (BMI), tobacco smoking (in pack-years)
and sex; these subjects with normal spirometry consti-
tuted 2 additional subgroups, namely, dairy farmers
without PAL (DF-Controls) and non-dairy farmers with-
out PAL (NF-Controls). Ethical approval was received
from the local Ethics Committee (CPP Est; 11/617), and
written consent was obtained from all subjects.
Procedures
During the “characterization” hospital visit, subjects had
a second spirometry test performed by a physician spe-
cialized in physiology, as well as several standardized
questionnaires and allergological examinations. The
medical questionnaire was an adapted French translation
of the long version of the European Community Respira-
tory Health Survey questionnaire [13, 14]. The occupa-
tional questionnaire was sent to the subjects 10 days
before their medical examination, collected during the
medical examination, and reviewed in the presence of
the subject [5, 15].
Total IgE concentration in the blood and allergen-
specific IgE against 21 common food and inhalant aller-
gens were assessed. Allergen mix was performed as the
first-line. If the allergen mix was positive, then allergen-
specific IgE were determined.
Blood assays were performed using enzyme-linked
immunosorbent assay (ELISA), ImmunoCAP® (Thermo-
Fisher Scientific/Phadia, Uppsala, Sweden), in the Bio-
chemistry Laboratory at the University Hospital of
Besançon, France. The total and allergen-specific IgE
concentration in the blood were dichotomized at the
detection limit of 100 kIU/L and 0.35 kUA/L, respect-
ively [16, 17]. A polysensitized patient was defined as a
subject having at least three positive tests for allergen-
specific IgE.
In addition, analyses of dust from each patient dwell-
ing and specific patient sensitization to his environment
have been previously published [18].
Statistical analysis
Qualitative variables are presented as number and percent-
age, and quantitative variables as mean ± standard deviation
(SD) or median and interquartile range (IQR) (Q1-Q3).
Characteristics of PAL and control subjects were
compared using the Student t-test or Wilcoxon test as
appropriate; and the Chi-square or Fisher’s exact test
as appropriate, for quantitative and qualitative vari-
ables, respectively.
Bivariate analyses were used to compare the results of
clinical and biological markers of atopy in DF-PAL vs
DF-controls, and in NF-PAL vs NF controls. The associ-
ation between these atopy markers and PAL in farmers
and PAL in non-farmers was assessed by using logistic
regressions with adjustment for age, smoking status (< 1
pack-year (reference), 1–15 pack-years and > 15 pack-
years) and sex (female as reference). Odds ratios are pre-
sented using forest plots. We used different multivariate
regression models to explain PAL in the whole popula-
tion in order to test the relevant atopy markers with ad-
justment for farming status, age, sex and smoking. Odds
ratios are given with 95% confidence intervals (CI).
A p-value < 0.05 was considered statistically signifi-
cant. Statistical analyses were performed using SAS ver-
sion 9.4 (SAS Institute, Inc., Cary, NC, USA).
Results
Among the 8106 subjects who underwent screening,
6704 were affiliated to the Mutualité Sociale Agricole
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(MSA), i.e. approximately 40% of the regional target
population for the free health check-up. The remaining
60% of subjects were sampled to assess the representa-
tiveness of our study population. Among the 8106 sub-
jects, 4963 met the inclusion criteria for the study
(60.8%). Among the 2384 farmers with interpretable
spirometry, 191 (8.01%) suffered from PAL. In total, 355
patients with PAL (191 dairy farmers and 164 non-
farmers) and 3188 patients with normal spirometry were
identified. 2 hundred and 10 PAL patients and 193 non-
PAL matched controls agreed to take part in the
“characterization” phase of the study during which 30
subjects had to be excluded, mainly owing to the exist-
ence of a history of asthma or to occupational exposure
other than dairy farming. Finally, a total of 373 subjects
were included: 101 DF-PAL, 98 DF-Controls, 85 NF-
PAL and 89 NF-Controls (Table 1 and Fig. 1).
A total of 365 subjects affiliated to the MSA and not
present at the screening were successfully contacted.
They were older on average (61.9 ± 10.0 vs 60.2 ± 9.7
years, p = 0.0014) and more often male (72.6% vs 57.5%,
p < 0.0001) than subjects who participated in the
screening, but their smoking status was not statistically
different. In addition, patients who participated in the hos-
pital “characterization” visit were not different from those
screened (PAL and non-PAL groups) in terms of smoking
status, sex-ratio, spirometry (% of theoretical values), but
they were younger (60.3 vs 64.2 years, p = 0.0047).
The main features of the four groups are summarized
in Table 1. Both PAL groups were composed mainly of
mild PAL with preserved FEV1. The proportion of
current-smokers and former-smokers was lower among
farmers than in non-farmers. The proportion of men
was higher among farmers than among non-farmers, but
the difference was not statistically significant.
The mean level of bronchodilation during the bron-
chodilation test was similar in DF-PAL and NF-PAL:
8.2% ± 8.2 vs 7.8% ± 7.5, p = 0.7202, respectively.
The atopy markers among the groups are shown in
Table 2. There was a statistically significant relation
between a self-reported personal history of allergy and
PAL. In dairy farmers, the frequency of sensitizations to
Table 1 Characteristics of the study patients (n = 373)
DF- COPD DF-Control p-value NF- COPD NF-Control p-value
n = 101 n = 98 n = 85 n = 89
Age, years 60.3 ± 9.1 59.3 ± 8.9 NS 61.4 ± 7.6 60.2 ± 6.5 NS
Men 86 (85.1) 86 (87.8) NS 66 (77.6) 65 (73.0) NS
BMI 26.5 ± 4.1 27.0 ± 4.1 NS 26.1 ± 4.1 26.8 ± 3.8 NS
Smoking status NS NS
Non-smoker 48 (47.5)** 54 (55.1) 7 (8.2) 12 (13.5)
Former-smoker 33 (32.7)** 32 (32.7) 36 (42.4) 42 (47.2)
Currentsmoker 20 (19.8)** 12 (12.2) 42 (49.4) 35 (39.3)
Smoking pack years NS NS
< 1 49 (48.5)** 55 (56.1) 7 (8.2) 13 (14.6)
1–15 18 (17.8)** 21 (21.4) 13 (15.3) 15 (16.9)
> 15 34 (33.7)** 22 (22.5) 65 (76.5) 61 (68.5)
Exacerbation 23 (22.8) 23 (27.1)
At least one respiratory symptom 54 (53.1) 21 (21.3) < 0.001 51 (60.0) 23 (25.9) < 0.001
Dyspnea, mMRC> 0 38 (38.0) 15 (15.3) < 0.001 39 (45.9) 19 (21.4) < 0.001
SGRQ 15.1 ± 12.9* 7.3 ± 7.2 < 0.001 19.4 ± 14.9 9.3 ± 9.3 < 0.001
FEV1 /FVC post-BD, %pred 63.0 ± 6.8* 78.5 ± 4.3 < 0.001 60.6 ± 8.0 79.9 ± 4.1 < 0.001
FEV1 post-BD, %pred; 85.2 ± 14.8* 105.5 ± 10.9 < 0.001 80.0 ± 16.4 108.3 ± 12.7 < 0.001
FVC post-BD, %pred; 105.3 ± 15.7 104.8 ± 11.4 NS 102.1 ± 14.8 105.7 ± 12.0 NS
Severity of airway obstruction, n (%)
Stage I 44 (44) 33 (39)
Stage II + 57 (56) 52 (61)
Data are presented as n, n (%) or mean ± SD, unless otherwise stated
COPD chronic obstructive pulmonary disease, DF-COPD dairy farmers with COPD, NF-COPD non-dairy farmers with COPD, SD standard deviation, BMI body mass
index, mMRC modified Medical Research Council, SGRQ St George’s Respiratory Questionnaire, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s
* p < 0.05, vs NF- COPD, ** p < 0.01, vs NF- COPD
Significant P values (< 0.05) are in bold
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Fig. 1 Flow chart of participants included in the study. Subjects were recruited through a screening program set up by two national health
insurance organizations. Inclusion criteria in the screening programs were: men or women aged 40 to 74 years, with no history of chronic
respiratory disease including asthma and hypersensitivity pneumonitis. Abbreviations: COPD: chronic obstructive lung disease; DF: dairy farmer;
NF: non farmer
Table 2 History of atopy, specific IgE level and total IgE amount among dairy-farmers and non-dairy-farmers
DF-COPD DF-Control p-value NF- COPD NF-Control p-value
n = 101 n = 98 n = 85 n = 89
Personal history of hay fever, % 8.9 10.2 NS 14.1 12.8 NS
Personal history of atopic dermatitis, % 5.0 5.1 NS 9.6 4.6 NS
Personal history of allergy, % 60.0 44.3 0.0277 70.2 52.8 0.0187
Family history of allergy, % 46.4 32.9 NS 42.6 41.1 NS
Wheezing, % 31.7 6.3 < 0.0001 29.4 11.2 0.0028
Total IgE amount
median (Q1-Q3) 40 (17–125) 37 (18–81) NS 42 (13–114) 28 (15–75) NS
> 100 IU/mL, % 30.3 24.7 NS 31.7 17.1 0.0256
Positive specific IgE (> 0.35 kUA/L)
At least one, % 21.8 14.4 NS 28.2 23.9 NS
Food allergens, % 16.8* 4.1 0.0037 7.1 5.6 NS
Perennial inhalant allergens, % 10.9 9.3 NS 10.6 12.4 NS
Seasonal inhalant allergens, % 11.9 3.1 0.0195 21.2 11.4 NS
Polysensitized (at least 3 IgE) 13.8 1.0 0.0006 8.2 6.7 NS
COPD chronic obstructive pulmonary disease, DF-COPD dairy farmers with COPD, NF-COPD non-dairy farmers with COPD, SD standard deviation, allergy was self
reported, history of allergy covered nasal allergies including hay fever, eczema or any kind of skin allergy, or allergy to insect stings or bites. * p < 0.05, vs
NF- COPD
Significant P values (< 0.05) are in bold
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food allergens and seasonal inhalant allergens was sig-
nificantly higher in DF-PAL. No significant relationship
was found between atopy markers and PAL in non-
farmers. Overall, specific IgEs were higher in the DF-
PAL group than in the DF-controls for all allergens
(Fig. 2). No significant relationship was found between
occupational exposure in dairy farming and PAL in
farmers (additional file 2).
As there were slight, albeit non-statistically significant
differences between PAL groups and their controls in
terms of age, gender and smoking, we adjusted for these
variables when comparing the distribution of biological
markers of atopy in PAL and controls separately in
farmers and in non-farmers (Fig. 3). Results showed a
higher prevalence of IgE sensitization only in PAL in
farmers (Fig. 3).
Then, we constructed three different models to deter-
mine factors associated with PAL in the whole popula-
tion. After adjustment for potential confounders, PAL
was mainly explained by the presence of biological atopy
markers and smoking (> 15 pack-years) (Table 3). The
use of the same models replacing PAL by FEV1 as the
outcome variable showed the same results. Models using
perennial inhalant allergens or at least one IgE were not
relevant. Regarding atopy markers, we did not find an
association with occupational exposure after adjustment
except for seasonal inhalant allergens which were in-
versely associated with diary farming (additional file 3).
Finally, non-smoker DF-PAL were compared to smoker
DF-PAL (current and former) for age, sex, clinical and bio-
logical atopy markers. No differences were identified.
Discussion
In this study, the frequency of atopy markers was higher
in PAL-groups than among controls, but the difference
was driven by a significantly higher rate among dairy
farmers only. Our study suggests that IgE-mediated reac-
tions may play a role in PAL development in dairy farm-
ing. This hypothesis is reinforced by the fact that in
farmers, there was no relationship between occupational
exposure and either PAL or atopy markers. Indeed, data
issued from the same cohort showed similar exposure
pattern among dairy farmers and therefore exposure
could not explain the occurrence of COPD [18]. This
may suggest a key role of individual factors in the gen-
esis of COPD in dairy farming.
Since atopy is not a usual characteristic for subjects
with COPD, this supports the hypothesis that COPD in
dairy farmers is different than COPD associated with to-
bacco smoking. Our results suggest that IgE-mediated
reactions (therefore possibly a Th2 cytokine production
profile) are involved in the development of COPD in
dairy farming. COPD due to tobacco smoking is domi-
nated by Th1-type lymphocyte response [6] and is asso-
ciated with Th17 cytokine production [7]. Conversely,
COPD induced by exposure to biomass smoke might be
associated with a predominantly Th2-type lymphocyte
production profile, as in asthma, and an increase of IL-4
[7, 19]. Moreover, emphysema is rarely found in this
type of COPD [7]. COPD in dairy farming could be close
to COPD induced by exposure to biomass smoke [19].
The involvement of atopy in COPD has never been ex-
tensively studied, to the best of our knowledge. Eduard
Fig. 2 Frequency histogram of specific IgE among dairy-farmers and non-dairy-farmers’ patientsCOPD: chronic obstructive pulmonary disease; DF-
COPD: dairy farmers with COPD; DF-control: dairy farmers in control group; NF- COPD: COPD in non-dairy farmers; NF-control: non-dairy farmers
in control group.
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et al. reported that Norwegian farmers with atopy had a
significantly lower FEV1 than non-atopic counterparts
[8]. However, in their study, no bronchodilation test was
performed, and the relationship between FEV1 and
atopy disappeared after the exclusion of asthmatics. In
addition, atopy was defined as a positive ImmunoCap®
result [8]. In our study, measurements of allergen-
specific IgEs against 21 common food and inhalant aller-
gens were performed. Another study in farmers showed
that a total IgE concentration > 180 kIU/L was associated
with lower FEV1 [20]. More recently, Cushen et al.
observed that among non-smoker Irish farmers, those
with lung obstruction more often had histories of hay
fever or allergies [21]. However, according to the
authors, the presence of asthmatics at least partly
explains these results. Nonetheless, in previous studies,
no significant relationships emerged between atopy
markers and COPD. Ours seems to be the first study
showing a strong link between markers of atopy and
COPD. In contrast with previous studies performed in
the Franche-Comté region [5], we did not find any link
between the level or type of occupational exposure and
agricultural COPD prevalence. The most likely explan-
ation is a progressive homogenization of occupational
exposure, with modernization of dairy farms over time.
The associations observed in our study between COPD
in dairy farmers and IgE sensitization concerns mainly
seasonal allergens. These results are in line with the
excess of prior history of personal allergy, and the higher
degree of wheezing observed in DF-COPD. However, the
absence of any difference between groups of farmers
regarding hay fever is unusual (Table 2). This is possibly
due to the fact that we excluded asthmatics and
consequently, allergic subjects. The relationship between
COPD in farmers and food allergens may be partially ex-
plained by cross-reactions between food and seasonal in-
halant allergens. It is noteworthy that the protection
against allergy conferred by dairy farming observed in
the large PASTURE European birth cohort that included
farmers living in the same region as the present study,
also concerned seasonal and food allergens, but not per-
ennial ones [22]. Dairy farming may be associated with a
reduced risk of lung cancer [23] and is known to protect
against allergy in children, but possibly also in adults [9].
Therefore, those who still develop atopy even with an
early-life farm exposure are those who may be at risk of
COPD. Besides, this occupational environment is also
known to generate COPD, especially in regions where
organics dusts and microorganisms constitute the main
exposure [4, 5]. We can therefore hypothesize that this
exposure in atopic subjects causes a bronchial disease dif-
ferent from asthma, which is characterized by a FEV1/
FVC ratio after bronchodilation < 0.7. Analyses of cyto-
kine measurements as well as IgE and IgG-mediated reac-
tions against microorganisms present in the home of the
studied subjects are planned and could be of substantial
interest in understanding the mechanisms of COPD in
dairy farmers.
Our study includes limitations inherent to a large
screening program. Only subjects who accepted to
undergo a health check-up were included in the COPD
screening program. In addition, only half the subjects
who had COPD detected by screening accepted to
attend the hospital visit for “characterization”. It has pre-
viously been reported that among all subjects who were
invited to health check-ups organized by the French
Fig. 3 Comparison of odds ratios for markers of atopy among dairy-farmers and non-dairy-farmers (reference groups are patients without chronic
obstructive pulmonary disease (COPD). All ORs were adjusted for age (continuous), gender (reference: female) and pack-years (< 1, 1–15, > 15)
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agricultural health insurance system, those who attend
these check-ups and those who do not have different
health characteristics [4]. It is therefore possible that our
population was not representative of the whole popula-
tion of dairy farmers (target population) regarding health
status. Our studied population, however, is not different
from the target population in terms of smoking habits.
There are significant differences for age and sex ratio,
but neither of these factors were associated with atopy
markers in the present analysis. Finally, our outcomes
can only be considered robust if we are sure that the
diagnosis of COPD was accurate, and that patients with
asthma were truly excluded. All reasonable precautions
were taken to verify the diagnosis of COPD. Spirome-
tries were performed by trained nurses during the
“screening” phase, followed by diagnostic confirmation
in the Department of Respiratory Medicine & Physiology
of our university hospital. Subjects with self-reported
asthma were excluded. Therefore, we can rule out an
asthma-COPD-overlap syndrome, which would have been
more frequent in DF-COPD. Farmer’s lung disease, an-
other possible differential diagnosis in our farming region,
was also ruled out by a question in the medical question-
naire and thanks to local expertise in this disease [24].
Conclusion
Dairy farmers with COPD are more polysensitized than
non-farming patients with COPD, and more polysensi-
tized, sensitized to food and seasonal inhalant allergens
than non-COPD subjects. These results expand the
hypothesis that atopy may be a risk indicator for COPD
in dairy farming, distinguishing it from COPD associated
with tobacco smoking.
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